Versatile, marker-free platform for life cycle-wide imaging of Plasmodium falciparum by integrating an exogenous gene cassette into a conserved intergenic locus Authors: Takashi Sekine, Naoaki Shinzawa, Rie Kubota, Daisuke Kobayashi, Yawara Okubo, Kentaro Itokawa, Haruhiko Isawa, Hisako Amino, Tomoko Ishino Published: 2026 ABSTRACT The creation of transgenic Plasmodium falciparum lines with robust fluorescence across the entire life cycle is essential for advancing our understanding of parasite biology, which in turn informs the development of new drugs and vaccines. In this study, we utilized Plasmodium-optimized genome editing to integrate an mCherry expression cassette into a selected intergenic locus without gene disruption. The resulting marker-free line, NF54-mCh, exhibited intense fluorescence throughout all developmental stages, including asexual and sexual blood stages, as well as mosquito (ookinete, oocyst, and sporozoite) and liver stages. NF54-mCh showed normal proliferation, gametocytogenesis, and efficient transmission to mosquitoes. The ultra-high brightness in salivary gland sporozoites allowed for the non-invasive identification of infected mosquitoes. Sporozoites remained highly infectious to humanized mouse livers, thus enabling the completion of the full life cycle. NF54-mCh serves as a parental line for performing additional genetic modifications, because the CRISPR/Cas9-based genome editing method is free of introduced drug resistance markers. The broader applicability of this strategy was validated by generating similar reporter lines in Plasmodium species utilized in rodent malaria models. In summary, NF54-mCh represents a unique, versatile platform that will accelerate fundamental research and support the future development of malaria control strategies, including new vaccines and drugs.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1038/s41598-026-55934-7. Introduction Malaria is caused by bloodstream infection with the protozoan Plasmodium parasite, and globally is a major infectious disease with 263 million cases and 597,000 deaths in 2023, according to WHO reports1. The emergence of Plasmodium falciparum blood stage antimalarial drug resistance to first-line antimalarials is a significant public health concern for malaria control. The first malaria vaccine, RTS,S, which targets sporozoites, was approved by the WHO in 20212 and presently is provided to children in African countries. However, its efficacy to prevent malaria infection appears to be limited and further improvements and vaccines are needed. To develop new interventions to eradicate malaria, it is necessary to understand the cellular and molecular biology of P. falciparum; especially during events such as parasite invasion of target cells, including hepatocytes and erythrocytes in humans, and epithelial cells and salivary glands in mosquitoes. The molecular mechanisms of Plasmodium have long been studied using genetically modified P. falciparum or rodent malaria parasites. However, human and rodent parasites show differing features indicative of their distinct evolutionary histories; such as dissimilar kinetics of parasite proliferation and differentiation during the intraerythrocytic and liver stages. For the development of new drug therapies or vaccines, it is ultimately necessary to conduct experiments with P. falciparum rather than rodent malaria parasite model systems. To monitor parasite development and to evaluate parasite infection, a P. falciparum parasite line which expresses a cytosolic fluorescent protein throughout its life cycle and possesses a wildtype phenotype would be a powerful research tool. For the improvement of infection-blocking vaccines, recent studies in the field of P. falciparum research have focused on mosquito stage analysis using blood feeding experiments and in vitro liver stage analysis using cultured hepatocytes or liver organoid culture3–8. Research is also being conducted utilizing immunodeficient humanized mice with transplanted human hepatocytes for in vivo analysis9–13; thereby expanding the methods available for analyzing the transmission mechanisms of the human-specific P. falciparum14–20. For localization and quantitative analyses in these liver models, it is advantageous to use parasites that constitutively express fluorescent proteins21. In past conventional methods, marker genes were integrated within select target genes which were dispensable for parasite development. For example, all P. falciparum lines that constitutively express fluorescent proteins and have been used for liver stage analysis were constructed with the disruption of the pfs47 gene22–26. However, because pfs47 plays a role in evasion mechanisms from the mosquito immune system27, it may not be a suitable platform for some investigations on mosquito-parasite interactions. In a previous report, it was shown that the introduction of an exogenous gene into an intergenic locus on chromosome 6 of Plasmodium berghei can produce a parasite strain that is phenotypically silent and emits green fluorescence28. Therefore, we hypothesized that insertion of a fluorescent protein expression cassette into a sufficiently long intergenic locus in the P. falciparum NF54 strain would also be successful and minimize the effects of transgenesis without gene disruption. We were additionally interested in addressing the issue of the drug resistance cassette, which remains in many fluorescent P. falciparum parasites21,24,26. The advent of CRISPR/Cas9 technology has significantly improved genome editing efficiency and ease of working with P. falciparum parasites, which historically required more challenging genetic modification methods than rodent malaria parasite model systems29–31. While a few marker-free lines have been developed by these highly efficient genome editing techniques, they often exhibit limitations such as reduced infectivity in liver stages or inconsistent fluorescence intensity across life cycle stages or impaired infectivity22,23. The generation of fluorescent P. falciparum parasites that are both marker-free and highly fluorescent at all stages is expected to facilitate the evaluation of the effects of gene knockouts and other modifications, thereby accelerating future elucidations of infection mechanisms. To address the above concerns, this study describes the generation of a Plasmodium falciparum parasite line, designated NF54-mCh, that constitutively expresses an mCherry fluorescent protein throughout its life cycle. Unlike traditional lines targeting the pfs47 gene, by integrating an mCherry cassette into a conserved intergenic locus on chromosome 10 using an improved CRISPR/Cas9 system, our strategy preserved the immune evasion machinery in the mosquito vector. The resulting parasites exhibited intense fluorescence across the life cycle; and the remarkable brightness in salivary glands facilitated the non-invasive identification of infected mosquitoes. This marker-free strain can serve as a parental line for further genetic modifications using drug-selectable markers. We also validated the broader utility of this intergenic locus by successfully generating a reporter-expressing parasite line in the rodent malaria parasites Plasmodium berghei and Plasmodium yoelii. Thus, this study provides a robust, versatile genetic platform that not only enhances our ability to perform high-resolution fluorescence imaging but also establishes a transformative tool for the future development of innovative malaria control strategies, including studies on new vaccines and drugs. Results Generation of a P. falciparum line which constitutively expresses mCherry To avoid gene disruption and minimize the impact of inserting an mCherry expressing cassette, we selected a region on chromosome 10 between the gene loci PF3D7_1022300 and PF3D7_1022400. This region was identified as one of the longest convergent intergenic spaces based on a reported dataset of gene boundaries32. Moreover, both flanking genes have been reported to be dispensable during asexual stages33,34; and therefore we concluded that this site is suitable for stable transgene integration with minimal fitness cost. The pfhsp90 promoter was chosen to drive an mCherry expression cassette, in anticipation that following integration into the intergenic locus, it would express the fluorescence marker in all P. falciparum mosquito and human life cycle stages (Fig. 1A). Integration was achieved using a CRISPR/Cas9 system via co-transfection of a linear donor DNA and a centromere plasmid expressing Cas9, an sgRNA and hDHFR-yFCU selectable marker35. A centromere plasmid was utilized to enhance the efficiency of plasmid maintenance and transformation in the parasites36. The NF54 line, which is known for its high gametocyte production, was used as the parental strain37, and the transfectants were selected via 10 days of pyrimethamine treatment. Diagnostic genotyping PCR of the parasites that emerged following drug withdrawal indicated that the mCherry cassette was introduced to the expected location (Fig. 1B). This transgenic parasite population was designated as NF54-mCh. In the parasites obtained after drug selection, the wildtype band was below the limit of detection (Fig. 1B), suggesting efficient genome editing. Two parasite clones were obtained by limiting dilution, in which only the mCherry expression cassette was integrated at the targeted intergenic locus, and were named NF54-mCh (B2) and NF54-mCh (D6). Southern blotting analysis confirmed the integration of the mCherry expression cassette exclusively at the expected locus (Fig. 1C). Whole genome sequencing of NF54-mCh (B2) was performed to assess the possibility that the CRISPR/Cas9 editing introduced unexpected mutations which might affect the parasite phenotype. A total of 13 indels and 2 SNPs unique to NF54-mCh were identified (Supplementary Table 1). All indels were located in AT-rich intergenic regions and an intron and are therefore unlikely to impact gene expression. The two SNPs were found within the repeat region of PF3D7_0322700 but were synonymous mutations. Therefore, whole genome sequencing of NF54-mCh indicated that the insertion of the mCherry expressing cassette did not affect genomic DNA integrity at any loci. Furthermore, PCR analysis using a primer set designed to detect the episomal plasmid showed no detectable band in the NF54-mCh (B2) clone. This indicates the loss of the plasmid during the culture period for limiting dilution, confirming that the drug-selectable marker is no longer present and that these parasites can be used for further genetic modifications (Supplementary Fig. 1). In the following analyses, NF54-mCh (B2) was utilized as the representative NF54-mCh line.Fig. 1Generation of mCherry expressing P. falciparum NF54. (A) A schematic representation of genome editing using the CRISPR/Cas9 system to integrate an mCherry expressing cassette into an intergenic locus of NF54 strain parasites. The donor DNA fragment (Donor) consisted of two homologous regions (LH and RH) and an mCherry coding region with a pfhsp90 promoter and a pfhsp70 3’UTR region. pCas9/sgRNA-cen plasmid contains a Pf centromere sequence (PfCen) and expresses Cas9 and hDHFR-yFCU under the pbef1a dual promoter, together with a guide RNA (sgRNA) expression cassette under the pfU6 promoter. The DNA integrated locus after transfection of these DNA fragments and plasmid into NF54 parasites is demonstrated below (NF54-mCh). The PCR primers p1 and p2 shown in Fig. 1B correspond to pfcheck-F and pfcheck-R. Restriction enzyme sites NheI and SpeI, and the probe used for genomic Southern blotting (Fig. 1C) are also indicated. LH, left homologous region; RH, right homologous region. (B) The genotyping PCR of transfected parasites. DNA fragments were amplified using p1 and p2 primers (indicated in A) with genomic DNA of transfected parasites and two clones obtained from limiting dilution. Longer fragments demonstrated that the mCherry expression cassette was correctly integrated at the indicated locus. The DNA size marker was indicated on the left. The original gel images are presented in Supplementary Fig. 4. (C) Genomic Southern blot hybridization analysis of NF54-mCh parasites. Genomic DNAs of NF54 and cloned NF54-mCh (B2) parasites were digested with NheI and SpeI, electrophoretically separated, and hybridized with either probe1 or probe2 indicated in A. The signals detected at approximately 18 kbp correspond to the genomic DNA fragment size after genome editing at the precise locus. A DNA size marker is indicated on the left. The original blot images are presented in Supplementary Fig. 4. Generation of mCherry expressing P. falciparum NF54. (A) A schematic representation of genome editing using the CRISPR/Cas9 system to integrate an mCherry expressing cassette into an intergenic locus of NF54 strain parasites. The donor DNA fragment (Donor) consisted of two homologous regions (LH and RH) and an mCherry coding region with a pfhsp90 promoter and a pfhsp70 3’UTR region. pCas9/sgRNA-cen plasmid contains a Pf centromere sequence (PfCen) and expresses Cas9 and hDHFR-yFCU under the pbef1a dual promoter, together with a guide RNA (sgRNA) expression cassette under the pfU6 promoter. The DNA integrated locus after transfection of these DNA fragments and plasmid into NF54 parasites is demonstrated below (NF54-mCh). The PCR primers p1 and p2 shown in Fig. 1B correspond to pfcheck-F and pfcheck-R. Restriction enzyme sites NheI and SpeI, and the probe used for genomic Southern blotting (Fig. 1C) are also indicated. LH, left homologous region; RH, right homologous region. (B) The genotyping PCR of transfected parasites. DNA fragments were amplified using p1 and p2 primers (indicated in A) with genomic DNA of transfected parasites and two clones obtained from limiting dilution. Longer fragments demonstrated that the mCherry expression cassette was correctly integrated at the indicated locus. The DNA size marker was indicated on the left. The original gel images are presented in Supplementary Fig. 4. (C) Genomic Southern blot hybridization analysis of NF54-mCh parasites. Genomic DNAs of NF54 and cloned NF54-mCh (B2) parasites were digested with NheI and SpeI, electrophoretically separated, and hybridized with either probe1 or probe2 indicated in A. The signals detected at approximately 18 kbp correspond to the genomic DNA fragment size after genome editing at the precise locus. A DNA size marker is indicated on the left. The original blot images are presented in Supplementary Fig. 4. Fluorescence in NF54-mCh asexual stages The proliferation rate of cultured NF54-mCh blood stage parasites was examined; and the growth of the two clones were comparable to the parental line NF54 (Fig. 2A). mCherry fluorescence was observed in the cytosol at each intraerythrocytic stage of NF54-mCh parasites by live-imaging using fluorescence microscopy (Fig. 2B). Thus NF54-mCh parasites express a strong mCherry signal throughout intraerythrocytic parasite development without affecting the growth rate.Fig. 2Asexual development of NF54-mCh parasites. (A) The comparison of parasite growth in vitro between NF54 parental and NF54-mCh parasites. Parasitemias of two clones of NF54-mCh parasites (red and blue) were comparable to those of the parental NF54 parasites (black). Dots indicate the mean values with standard deviations as error bars from three independent experiments. There were no significant differences in parasitemias on each day among the parasite lines using the unpaired t-test. (B) mCherry expression during asexual development in NF54-mCh. Thin smears of NF54-mCh infected erythrocytes were made without fixation, and mCherry fluorescence (red, top panels) was captured using a fluorescence microscope. All mCherry images were captured with the same exposure time, except for an image in the insert, which was taken with a longer exposure time to visualize its signal at the ring stage (upper-right in “Ring”). Nuclei were stained with Hoechst 33342 (cyan, middle panels). Phase images are shown below. The bar indicates 10 µm. Asexual development of NF54-mCh parasites. (A) The comparison of parasite growth in vitro between NF54 parental and NF54-mCh parasites. Parasitemias of two clones of NF54-mCh parasites (red and blue) were comparable to those of the parental NF54 parasites (black). Dots indicate the mean values with standard deviations as error bars from three independent experiments. There were no significant differences in parasitemias on each day among the parasite lines using the unpaired t-test. (B) mCherry expression during asexual development in NF54-mCh. Thin smears of NF54-mCh infected erythrocytes were made without fixation, and mCherry fluorescence (red, top panels) was captured using a fluorescence microscope. All mCherry images were captured with the same exposure time, except for an image in the insert, which was taken with a longer exposure time to visualize its signal at the ring stage (upper-right in “Ring”). Nuclei were stained with Hoechst 33342 (cyan, middle panels). Phase images are shown below. The bar indicates 10 µm. Normal development of gametocytes was observed in the NF54-mCh parasite To examine the effect of mCherry expression on sexual stage development, gametocytes were induced from in vitro asexual stage cultures by adding human serum without supplying new erythrocytes for 17 days. Gametocytemias were measured from day 10 post induction by Giemsa staining of blood smears on glass slides; and were comparable between the NF54-mCh clones and the parental NF54 line (Fig. 3A). An immunofluorescent assay (IFA) using anti-α-tubulin and anti-PfG377 marker antibodies was performed to calculate the proportion of female and male gametocytes. Specifically, male gametocytes showed stronger α-tubulin signals, while female gametocytes showed stronger PfG377 signals in their cytosol38; and thusly the female/male ratios in the NF54-mCh clones were observed to be comparable to the parental line (Fig. 3B). mCherry fluorescence was clearly detected throughout gametocyte maturation (Fig. 3C).Fig. 3Development and maturation of NF54-mCh gametocytes. (A) The gametocytemias of NF54-mCh parasites after induction during in vitro culture. Bars show the means of three independent gametocyte cultures, and error bars indicate standard errors. Distributions were compared using the unpaired t-test (not significant). (B) (Left) The ratio of male and female gametocytes within NF54-mCh cultures. Bars show the means of three independent gametocyte cultures, and error bars indicate standard errors. Distributions were compared using the unpaired t-test and were not significant. (Right) Female and male gametocytes were detected with rabbit anti-PfG377 antiserum (green) and mouse anti-α-tubulin monoclonal antibody (red), respectively. Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. (C) Representative images during NF54-mCh gametocyte maturation. Thin smears of NF54-mCh infected erythrocytes were made without fixation, and mCherry fluorescence (red, top panels) was captured using a fluorescence microscope. Nuclei were stained with Hoechst 33342 (cyan, middle panels) and phase images (lower panels) are shown. The indicated gametocyte stages were determined by their morphologies. The bar indicates 10 µm. All images were captured with the same exposure time. (D) Representative images of an activated male gametocyte and a microgamete of NF54-mCh. Cultured parasites were incubated with human serum for 15 min before making thin smears. mCherry fluorescence (red) together with nuclei stained with Hoechst 33342 (cyan) are shown in the upper panels. Giemsa staining images of activated parasites are shown in the lower panels. The bar indicates 10 µm. (E) The number of exflagellation centers of the NF54-mCh after in vitro gametocyte activation. The mean number of exflagellation centers per 105 erythrocytes from three independent experiments using NF54 (black) and two NF54-mCh clones (red and blue) are shown as symbols with error bars indicating standard errors. The day of activation after gametocyte culture is indicated below. No significant difference was observed in the number of activated male gametocytes throughout the days examined by the unpaired t-test. (F) The evaluation of female gametocyte egress from erythrocytes. Cultured NF54-mCh parasites containing mature gametocytes were incubated with or without human serum for 15 min before fixation with 4% paraformaldehyde. Female gametocytes and erythrocyte membranes were detected by mouse anti-Pfs25 monoclonal antibodies (green) and rabbit anti-human erythrocyte polyclonal antibodies (magenta), respectively. Nuclei were stained with Hoechst 33342 (cyan). Merged images are shown in the right panels. Upon activation, a female gametocyte egressed from an erythrocyte (yellow arrowhead, lower panels). The white arrowhead indicates an uninfected red blood cell. The bar indicates 10 µm. Development and maturation of NF54-mCh gametocytes. (A) The gametocytemias of NF54-mCh parasites after induction during in vitro culture. Bars show the means of three independent gametocyte cultures, and error bars indicate standard errors. Distributions were compared using the unpaired t-test (not significant). (B) (Left) The ratio of male and female gametocytes within NF54-mCh cultures. Bars show the means of three independent gametocyte cultures, and error bars indicate standard errors. Distributions were compared using the unpaired t-test and were not significant. (Right) Female and male gametocytes were detected with rabbit anti-PfG377 antiserum (green) and mouse anti-α-tubulin monoclonal antibody (red), respectively. Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. (C) Representative images during NF54-mCh gametocyte maturation. Thin smears of NF54-mCh infected erythrocytes were made without fixation, and mCherry fluorescence (red, top panels) was captured using a fluorescence microscope. Nuclei were stained with Hoechst 33342 (cyan, middle panels) and phase images (lower panels) are shown. The indicated gametocyte stages were determined by their morphologies. The bar indicates 10 µm. All images were captured with the same exposure time. (D) Representative images of an activated male gametocyte and a microgamete of NF54-mCh. Cultured parasites were incubated with human serum for 15 min before making thin smears. mCherry fluorescence (red) together with nuclei stained with Hoechst 33342 (cyan) are shown in the upper panels. Giemsa staining images of activated parasites are shown in the lower panels. The bar indicates 10 µm. (E) The number of exflagellation centers of the NF54-mCh after in vitro gametocyte activation. The mean number of exflagellation centers per 105 erythrocytes from three independent experiments using NF54 (black) and two NF54-mCh clones (red and blue) are shown as symbols with error bars indicating standard errors. The day of activation after gametocyte culture is indicated below. No significant difference was observed in the number of activated male gametocytes throughout the days examined by the unpaired t-test. (F) The evaluation of female gametocyte egress from erythrocytes. Cultured NF54-mCh parasites containing mature gametocytes were incubated with or without human serum for 15 min before fixation with 4% paraformaldehyde. Female gametocytes and erythrocyte membranes were detected by mouse anti-Pfs25 monoclonal antibodies (green) and rabbit anti-human erythrocyte polyclonal antibodies (magenta), respectively. Nuclei were stained with Hoechst 33342 (cyan). Merged images are shown in the right panels. Upon activation, a female gametocyte egressed from an erythrocyte (yellow arrowhead, lower panels). The white arrowhead indicates an uninfected red blood cell. The bar indicates 10 µm. To examine the transmission ability of NF54-mCh parasites to mosquitoes, firstly the number of exflagellation centers were counted as an indicator of the capacity of male gametocytes to differentiate into gametes after being ingested by mosquitoes. Gametogenesis was induced by incubating mature gametocytes in human serum for 15 min at room temperature39, and then the released microgametes expressing mCherry were counted using a microscope (Fig. 3D). The numbers of exflagellation centers of NF54-mCh from days 14 to 17 post gametocyte-induction were comparable to those of the NF54 parental line (Fig. 3E). Female gametocyte activation was measured by IFA using anti-Pfs25 and anti-human erythrocyte antibodies. As shown in Fig. 3F, activated, rounded mCherry expressing macrogametes were observed which were egressed from erythrocytes. These results indicated that NF54-mCh parasites differentiated normally into sexual stage parasites and strongly expressed cytosolic fluorescence. NF54-mCh parasites develop normally in Anopheles mosquitoes For P. falciparum, gamete fertilization and ookinete transformation cannot be fully replicated in vitro, making it necessary to analyze the development of these stages using the mosquito host40. This caveat in turn emphasizes that fluorescence-expressing parasites are a particularly useful tool for monitoring infection and localization during parasite invasion and maturation in mosquito vectors. NF54 and NF54-mCh parasite transmission to Anopheles stephensi mosquitoes was performed by membrane-feeding using gametocytes at day 17 post-induction. Ookinetes harvested from NF54-mCh infected mosquito midguts at 24 h post-feeding showed strong cytosolic mCherry signals (Fig. 4A). At 8 to 10 days post-feeding, mCherry-positive oocysts were observed on dissected midguts (Fig. 4B), and the oocyst numbers were comparable between NF54-mCh and the NF54 parental line (Fig. 4C and Supplementary Fig. 2). mCherry fluorescence originating from NF54-mCh sporozoites was sufficiently strong to be detected from the outside of salivary glands (Fig. 4D, E), as well as from the outside of infected mosquitoes (Fig. 4F). Dissection of infected salivary glands at days 18 to 20 post-feeding showed comparable numbers of NF54-mCh versus NF54 wild type sporozoites (Fig. 4G). Because sporozoites residing in salivary glands are inoculated into the human skin through mosquito bites, the finding that NF54-mCh and NF54 parental line sporozoites accumulated in salivary glands with similar efficiency suggested that the transmission efficacy of NF54-mCh parasites via mosquitoes is likely equivalent to its parental strain.Fig. 4NF54-mCh parasite transmission to mosquitoes. (A) Representative images of mCherry fluorescence during ookinete maturation in mosquito midguts. A homogenate of midguts collected from NF54-mCh infected mosquitoes at day 1 post-feeding was smeared on a glass slide to detect mCherry (red), with nuclei stained with Hoechst 33342 (cyan). Giemsa staining ookinetes are shown below. The bar indicates 10 µm. (B) A representative image of mCherry expression in oocysts on the midgut of an NF54-mCh infected A. stephensi mosquito. Midguts were dissected at days 8 to 10 post-feeding and observed using a fluorescence microscope with a phase image. The bar in the left panel indicates 100 µm, and the right indicates 20 µm. (C) The comparison of oocyst number on mosquito midguts between the NF54 parental line and NF54-mCh. Midguts were collected at days 8 to 10 post-feeding and visualized by staining with mercurochrome. Each dot represents the number of oocysts from an individual midgut, with horizontal lines indicating the median. The Mann–Whitney test was used to compare distributions (N = 60). (D) Representative images of an mCherry expressing sporozoite. Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. (E) Micrographs of a sporozoite-containing salivary gland. A salivary gland from an NF54-mCh infected mosquito was collected at days 18 to 20 post-feeding and stained with Hoechst 33342 to visualize gland nuclei (blue). Fluorescence images are shown as max-intensity projections of confocal stacks. The bar indicates 100 µm. (F) External view of a live A. stephensi mosquito showing salivary gland fluorescence. The picture was captured at days 16 post-feeding. The arrowhead indicates mCherry signals in the salivary glands. A scale bar indicates 500 µm. (G) The number of sporozoites collected from mosquito salivary glands at days 18 to 20 post-feeding. Seventy pairs of salivary glands were collected from NF54 or NF54-mCh infected mosquitoes to count sporozoites that successfully invaded salivary glands. Each dot represents the number of pooled sporozoites from ten mosquitos. Bars show the mean numbers from biological septuplicate with error bars indicating standard deviations. The Mann–Whitney test was used to compare distributions (not significant). NF54-mCh parasite transmission to mosquitoes. (A) Representative images of mCherry fluorescence during ookinete maturation in mosquito midguts. A homogenate of midguts collected from NF54-mCh infected mosquitoes at day 1 post-feeding was smeared on a glass slide to detect mCherry (red), with nuclei stained with Hoechst 33342 (cyan). Giemsa staining ookinetes are shown below. The bar indicates 10 µm. (B) A representative image of mCherry expression in oocysts on the midgut of an NF54-mCh infected A. stephensi mosquito. Midguts were dissected at days 8 to 10 post-feeding and observed using a fluorescence microscope with a phase image. The bar in the left panel indicates 100 µm, and the right indicates 20 µm. (C) The comparison of oocyst number on mosquito midguts between the NF54 parental line and NF54-mCh. Midguts were collected at days 8 to 10 post-feeding and visualized by staining with mercurochrome. Each dot represents the number of oocysts from an individual midgut, with horizontal lines indicating the median. The Mann–Whitney test was used to compare distributions (N = 60). (D) Representative images of an mCherry expressing sporozoite. Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. (E) Micrographs of a sporozoite-containing salivary gland. A salivary gland from an NF54-mCh infected mosquito was collected at days 18 to 20 post-feeding and stained with Hoechst 33342 to visualize gland nuclei (blue). Fluorescence images are shown as max-intensity projections of confocal stacks. The bar indicates 100 µm. (F) External view of a live A. stephensi mosquito showing salivary gland fluorescence. The picture was captured at days 16 post-feeding. The arrowhead indicates mCherry signals in the salivary glands. A scale bar indicates 500 µm. (G) The number of sporozoites collected from mosquito salivary glands at days 18 to 20 post-feeding. Seventy pairs of salivary glands were collected from NF54 or NF54-mCh infected mosquitoes to count sporozoites that successfully invaded salivary glands. Each dot represents the number of pooled sporozoites from ten mosquitos. Bars show the mean numbers from biological septuplicate with error bars indicating standard deviations. The Mann–Whitney test was used to compare distributions (not significant). NF54-mCh sporozoites successfully infect human hepatocytes to release infective hepatic merozoites in a humanized mouse model To assess the ability of hepatocyte infection, NF54-mCh sporozoites dissected from mosquito salivary glands were inoculated onto the hepatocyte-derived immortalized cell line, HC-04, which supports P. falciparum liver stage parasite development41. NF54-mCh sporozoites were capable of infecting HC-04 cells and showed nuclei division within parasitophorous vacuoles (Fig. 5A). Strong cytosolic expression of mCherry was observed in the NF54-mCh liver stage parasites. The infectivity of NF54-mCh hepatic merozoites to erythrocytes was then examined; and thereby conceptual completion of the parasite life cycle. While the production of infectious hepatic merozoites in vitro remains challenging and inconsistent, an in vivo infection system using human liver chimeric mice, in which hepatocytes are replaced by human hepatocytes, can be applied for the evaluation of the infectivity of hepatic merozoites12. To account for individual variability among mice, a total of 0.1 × 106 sporozoites, consisting of a mixture of NF54-mCh and NF54 sporozoites at a ratio of 10:7, were intravenously inoculated into a single humanized mouse. At days 6 and 8 post sporozoite inoculation, human erythrocytes were intravenously inoculated into the infected mouse, and then blood was collected 4 h after the second erythrocyte inoculation to serve for in vitro parasite culture (Fig. 5B). One day after the initiation of the in vitro culture, both mCherry-positive and negative ring forms were detected within blood smears (Fig. 5C). On day 4 after establishment of the in vitro culture, parasites were counted and the ratio of NF54-mCh parasites to NF54 parasites was 10:7 (116 NF54-mCherry and 84 NF54 parasites out of 200 total parasites counted). Since the proportion of parasites that emerged in the blood was comparable to the ratio of the inoculated sporozoites, it was concluded that there is no significant difference between NF54-mCh and the NF54 parental line with respect to sporozoite infectivity or the efficiency of liver stage development.Fig. 5NF54-mCh sporozoite infection of hepatocytes. (A) NF54-mCh parasite development inside hepatocytes. HC-04 cells were fixed with 4% paraformaldehyde 5 days after NF54-mCh sporozoite inoculation. Cells were labeled with rabbit anti-EXP2 antibodies (green), together with Hoechst 33342 (blue). Micrographs of a confocal section of the liver stage parasite are shown. N indicates the host cell nucleus. The bar indicates 10 µm. (B) Workflow to evaluate P. falciparum sporozoite infectivity to a human liver chimeric mouse. Sporozoites collected from salivary glands were intravenously injected into a human liver chimeric mouse, followed by human erythrocytes inoculation at days 6 and 8 post-inoculation. Blood was collected 4 h after the second erythrocyte inoculation, which was subjected to in vitro culture in complete medium. (C) Reappearance of blood-stage parasites through the in vivo liver stage. Ring stage parasites were detected on the next day from the start of in vitro culture indicated at B. Closed arrowheads and open arrowheads indicate NF54 and NF54-mCh parasites, distinguished by mCherry expression (red). Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. NF54-mCh sporozoite infection of hepatocytes. (A) NF54-mCh parasite development inside hepatocytes. HC-04 cells were fixed with 4% paraformaldehyde 5 days after NF54-mCh sporozoite inoculation. Cells were labeled with rabbit anti-EXP2 antibodies (green), together with Hoechst 33342 (blue). Micrographs of a confocal section of the liver stage parasite are shown. N indicates the host cell nucleus. The bar indicates 10 µm. (B) Workflow to evaluate P. falciparum sporozoite infectivity to a human liver chimeric mouse. Sporozoites collected from salivary glands were intravenously injected into a human liver chimeric mouse, followed by human erythrocytes inoculation at days 6 and 8 post-inoculation. Blood was collected 4 h after the second erythrocyte inoculation, which was subjected to in vitro culture in complete medium. (C) Reappearance of blood-stage parasites through the in vivo liver stage. Ring stage parasites were detected on the next day from the start of in vitro culture indicated at B. Closed arrowheads and open arrowheads indicate NF54 and NF54-mCh parasites, distinguished by mCherry expression (red). Nuclei were stained with Hoechst 33342 (cyan). The bar indicates 10 µm. The intergenic locus shows synteny with rodent malaria parasite genomes and can be used for targeted integration of expression cassettes The potential utility of the intergenic region used for the integration of mCherry in P. falciparum was explored in other malaria parasite species as a locus for the integration of exogenous DNA. Specifically, we aimed to insert a reporter protein expressing cassette into the syntenic intergenic region between PBANKA_0506500 and PBANKA_0506600 on chromosome 5 of the rodent malaria parasite, Plasmodium berghei ANKA (PbANKA) (Fig. 6A). We attempted to express two reporter proteins, mGreenLantern (mGL), a brighter variant of GFP42, and Akaluc, a red-shifted variant of firefly luciferase43, fused by a self-cleaving peptide, T2A, and controlled by the universal promoter pbhsp70. Genotyping PCR and Western blotting analysis confirmed the correct integration into the syntenic intergenic region; and therefore, we named this transgenic parasite Pb-mGL-Aka (Fig. 6B, C).Fig. 6Generation of mGreenLantern-Akaluc expressing P. berghei. (A) A schematic representation of CRISPR/Cas9 system genome editing to integrate an mGreenLantern-Akaluc expression cassette into an intergenic locus. The donor DNA fragment consisted of two homologous regions (LH and RH) and an mGreenLantern-Akaluc coding region with a pbhsp70 promoter and pbhsp70 3’UTR. pCas9/sgRNA expresses Cas9 and hDHFR-yFCU under a pbef1a dual promoter together with guide RNA (sgRNA) under a pfU6 promoter. The DNA integrated locus after transfection of these DNA fragments and plasmid into PbANKA parasites is demonstrated below (Pb-mGL-Aka). The PCR primers p1 and p2 shown in Fig. 6B correspond to pbcheck-F and pbcheck-R. LH, left homologous region; RH, right homologous region. (B) The genotyping PCR of transfected parasites. DNA fragments were amplified using p1 and p2 primers (indicated in A) with genomic DNA of transfected parasites and a clone obtained following limiting dilution. Longer fragments demonstrated that the mGreenLantern-Akaluc expression cassette was correctly integrated at the indicated locus. The DNA size marker is indicated on the left. The original gel image is presented in Supplementary Fig. 4. (C) Western blot analysis of Pb-mGL-Aka. Schizonts of PbANKA and Pb-mGL-Aka parasites were collected for the analysis. Samples were adjusted to contain 1 × 106 parasites and extracts were electrophoretically separated, transferred to membranes, and subjected to Western blot analysis. Antibodies against luciferase and GFP were used to detect the respective proteins. Pbhsp70 antibody was employed as a loading control. Using the anti-luciferase antibody, two bands at approximately 90 kDa and 60 kDa were detected in Pb-mGL-Aka, corresponding to the mGL-Akaluc fusion protein and the cleaved Akaluc protein, respectively. Similarly, probing with the anti-GFP antibody revealed bands at approximately 90 kDa and 30 kDa, representing the fusion protein and cleaved mGL, respectively. Arrowhead, closed circle, and an open circle represent the 90 kDa, 60 kDa, and 30 kDa bands, respectively. The original blot images are presented in Supplementary Fig. 4. Generation of mGreenLantern-Akaluc expressing P. berghei. (A) A schematic representation of CRISPR/Cas9 system genome editing to integrate an mGreenLantern-Akaluc expression cassette into an intergenic locus. The donor DNA fragment consisted of two homologous regions (LH and RH) and an mGreenLantern-Akaluc coding region with a pbhsp70 promoter and pbhsp70 3’UTR. pCas9/sgRNA expresses Cas9 and hDHFR-yFCU under a pbef1a dual promoter together with guide RNA (sgRNA) under a pfU6 promoter. The DNA integrated locus after transfection of these DNA fragments and plasmid into PbANKA parasites is demonstrated below (Pb-mGL-Aka). The PCR primers p1 and p2 shown in Fig. 6B correspond to pbcheck-F and pbcheck-R. LH, left homologous region; RH, right homologous region. (B) The genotyping PCR of transfected parasites. DNA fragments were amplified using p1 and p2 primers (indicated in A) with genomic DNA of transfected parasites and a clone obtained following limiting dilution. Longer fragments demonstrated that the mGreenLantern-Akaluc expression cassette was correctly integrated at the indicated locus. The DNA size marker is indicated on the left. The original gel image is presented in Supplementary Fig. 4. (C) Western blot analysis of Pb-mGL-Aka. Schizonts of PbANKA and Pb-mGL-Aka parasites were collected for the analysis. Samples were adjusted to contain 1 × 106 parasites and extracts were electrophoretically separated, transferred to membranes, and subjected to Western blot analysis. Antibodies against luciferase and GFP were used to detect the respective proteins. Pbhsp70 antibody was employed as a loading control. Using the anti-luciferase antibody, two bands at approximately 90 kDa and 60 kDa were detected in Pb-mGL-Aka, corresponding to the mGL-Akaluc fusion protein and the cleaved Akaluc protein, respectively. Similarly, probing with the anti-GFP antibody revealed bands at approximately 90 kDa and 30 kDa, representing the fusion protein and cleaved mGL, respectively. Arrowhead, closed circle, and an open circle represent the 90 kDa, 60 kDa, and 30 kDa bands, respectively. The original blot images are presented in Supplementary Fig. 4. In the Pb-mGL-Aka parasites, green fluorescence of mGL was clearly observed throughout the blood stages as well as in gametocytes (Fig. 7A). Fluorescence was also observed in the mosquito stages; that is, ookinetes, oocysts, and sporozoites (Fig. 7B–E). The numbers of oocysts and sporozoites were compared with those of the parental line, and no significant differences were observed (Fig. 7F, G). To explore whether the liver stage parasites could be measured by luciferase activity from Akaluc, 10 × 103 Pb-mGL-Aka sporozoites were intravenously inoculated into an ICR mouse. Twenty-four hours later, the Akaluc substrate was injected to the mouse and bioluminescence was detected (Fig. 7H). Pb-mGL-Aka parasites were able to infect mice and proliferate in vivo with comparable efficiency to PbANKA following the intravenous injection of 2000 sporozoites into C57BL/6 mice. (Fig. 7I). These results demonstrate that the insertion of an mGreenLantern-Akaluc expression cassette into the intergenic locus in P. berghei chromosome 5 drives expression of bright green fluorescence through the life cycle without interfering with P. berghei parasite infection and proliferation. Similarly, introduction of the mGL expression cassette into an intergenic locus of Plasmodium yoelii resulted in detectable fluorescence in the blood stages, oocysts, and sporozoites (Supplementary Fig. 3). These findings support that this intergenic locus serves as a permissive site for the integration of exogenous genes in P. falciparum, P. berghei, and P. yoelii.Fig. 7mGreenLantern and Akaluc expression throughout the parasite life cycle. (A) mGreenLantern expression during asexual development and gametocytes in Pb-mGL-Aka. Thin smears of Pb-mGL-Aka infected erythrocytes were made without fixation, and mGreenLantern fluorescence (green, top panels) was captured using a fluorescence microscope. All mGreenLantern images were captured with the same exposure time. Nuclei were stained with Hoechst 33342 (cyan, middle panels). Phase images are shown below. The bar indicates 10 µm. (B) Representative images of mGreenLantern fluorescence during ookinete maturation. The bar indicates 10 µm. (C) A representative image of mGreenLantern expressing midgut oocysts within a Pb-mGL-Aka infected A. stephensi mosquito. A midgut was dissected at day 10 post-feeding and observed using a fluorescence microscope with a phase image. The bar indicates 100 µm. (D) Micrographs of a sporozoite-containing salivary gland. The salivary gland of Pb-mGL-Aka infected mosquito was collected at day 20 post-feeding and stained with Hoechst 33342 to visualize gland nuclei (blue) and CellMask™ Orange to visualize plasma membranes (red). Fluorescent images are shown as max-intensity projections of confocal stacks. The bar indicates 100 µm. (E) Representative images of an mGreenLantern expressing sporozoite. Sporozoites collected in Fig. 7C were stained with Hoechst 33342 (cyan) and observed using a fluorescence microscope. The bar indicates 10 µm. (F) The comparison of oocyst number on mosquito midguts between PbANKA and Pb-mGL-Aka. Midguts were collected at day 10 post-feeding and stained with mercurochrome to count. Each dot represents the number of oocysts from an individual midgut with horizontal lines indicating the median. The Mann–Whitney test was used to compare distributions (N = 30). (G) The number of Pb-mGL-Aka sporozoites collected from mosquito salivary glands were comparable to those of the PbANKA parental line. Fifteen pairs of salivary glands were collected at day 20 post-feeding from PbANKA or Pb-mGL-Aka infected mosquitoes, and sporozoites were counted that successfully invaded salivary glands. Each dot represents the number of pooled sporozoites from five mosquitos. Bars show the mean numbers from biological triplicates with error bars indicating standard deviations. The Mann–Whitney test was used to compare distributions (N = 3). (H) 10 × 103 sporozoites of the Pb transgenic parasite were injected into an ICR mouse and liver stage development was visualized by measuring luciferase activity 24 h after inoculation. (I) Comparison of parasite growth in infected C57BL/6 mice between PbANKA and Pb-mGL-Aka parasites. A total of 2000 PbANKA or Pb-mGL-Aka sporozoites were intravenously injected into C57BL/6 mice, and blood parasitemias were determined using Giemsa-stained blood smears. Parasitemia levels of Pb-mGL-Aka parasites (green) were comparable to those of the parental PbANKA strain (black). Error bars represent the standard error of the mean (SEM) from five mice. mGreenLantern and Akaluc expression throughout the parasite life cycle. (A) mGreenLantern expression during asexual development and gametocytes in Pb-mGL-Aka. Thin smears of Pb-mGL-Aka infected erythrocytes were made without fixation, and mGreenLantern fluorescence (green, top panels) was captured using a fluorescence microscope. All mGreenLantern images were captured with the same exposure time. Nuclei were stained with Hoechst 33342 (cyan, middle panels). Phase images are shown below. The bar indicates 10 µm. (B) Representative images of mGreenLantern fluorescence during ookinete maturation. The bar indicates 10 µm. (C) A representative image of mGreenLantern expressing midgut oocysts within a Pb-mGL-Aka infected A. stephensi mosquito. A midgut was dissected at day 10 post-feeding and observed using a fluorescence microscope with a phase image. The bar indicates 100 µm. (D) Micrographs of a sporozoite-containing salivary gland. The salivary gland of Pb-mGL-Aka infected mosquito was collected at day 20 post-feeding and stained with Hoechst 33342 to visualize gland nuclei (blue) and CellMask™ Orange to visualize plasma membranes (red). Fluorescent images are shown as max-intensity projections of confocal stacks. The bar indicates 100 µm. (E) Representative images of an mGreenLantern expressing sporozoite. Sporozoites collected in Fig. 7C were stained with Hoechst 33342 (cyan) and observed using a fluorescence microscope. The bar indicates 10 µm. (F) The comparison of oocyst number on mosquito midguts between PbANKA and Pb-mGL-Aka. Midguts were collected at day 10 post-feeding and stained with mercurochrome to count. Each dot represents the number of oocysts from an individual midgut with horizontal lines indicating the median. The Mann–Whitney test was used to compare distributions (N = 30). (G) The number of Pb-mGL-Aka sporozoites collected from mosquito salivary glands were comparable to those of the PbANKA parental line. Fifteen pairs of salivary glands were collected at day 20 post-feeding from PbANKA or Pb-mGL-Aka infected mosquitoes, and sporozoites were counted that successfully invaded salivary glands. Each dot represents the number of pooled sporozoites from five mosquitos. Bars show the mean numbers from biological triplicates with error bars indicating standard deviations. The Mann–Whitney test was used to compare distributions (N = 3). (H) 10 × 103 sporozoites of the Pb transgenic parasite were injected into an ICR mouse and liver stage development was visualized by measuring luciferase activity 24 h after inoculation. (I) Comparison of parasite growth in infected C57BL/6 mice between PbANKA and Pb-mGL-Aka parasites. A total of 2000 PbANKA or Pb-mGL-Aka sporozoites were intravenously injected into C57BL/6 mice, and blood parasitemias were determined using Giemsa-stained blood smears. Parasitemia levels of Pb-mGL-Aka parasites (green) were comparable to those of the parental PbANKA strain (black). Error bars represent the standard error of the mean (SEM) from five mice. Discussion In this study, we introduced an mCherry expression cassette into an intergenic locus of the P. falciparum NF54 line using the CRISPR/Cas9 system. The resulting NF54-mCh line exhibits robust fluorescence throughout the parasite life cycle, encompassing the blood, mosquito, and liver stages. The strong fluorescence of oocysts facilitates the assessment of parasite transmission to mosquitoes, which enables simpler quantification of the efficacy of transmission-blocking antibodies. The intense fluorescence of salivary gland sporozoites allows for visual detection of infected mosquitoes without dissection, thereby aiding mosquito dissection procedures. In the liver stage, NF54-mCh exhibits robust and constitutive fluorescence from the early stages of infection, with infection rates comparable to the parental line, NF54. The NF54-mCh parasites lacked difficulties observed in other transgenic P. falciparum lines, such as insufficient fluorescence in sporozoites and lower infection efficiency in hepatocytes22,23. To the best of our knowledge, NF54-mCh is the first transgenic parasite line to combine high-intensity fluorescence in salivary gland sporozoites with robust development throughout the liver stage. This may be attributed to the pfhsp90 promoter which was used to drive mCherry expression; as well as the strategic choice of the intergenic integration locus, which likely ensures stable and high-level transgene expression. The NF54-mCh parasites were able to develop through various life cycle stages in vitro, and in vivo in mosquitoes, and in humanized mice, demonstrating that the introduction of exogenous genes does not interfere with parasite fitness. Because NF54-mCh does not contain a drug resistance cassette, the parasites can be used as a parental line for further genetic modification. In addition, it is notable that no genes were disrupted in the NF54-mCh line because an intergenic locus was used as a target for introducing exogenous genes. For example, NF54-mCh retains an intact pfs47 locus, which is frequently disrupted in other fluorescent parasite lines; and therefore, its ability to infect refractory mosquito species should be conserved27. In summary, we believe that NF54-mCh is a valuable tool that will accelerate aspects of P. falciparum research, including parasite development and mosquito-parasite interaction. An exogenous gene expression cassette was also introduced into the orthologous region of the rodent malaria parasites P. berghei and P. yoelii; and the fluorescence reporter was expressed across all life cycle stages without compromising parasite development. This success indicates that this syntenic locus is a suitable target across different Plasmodium species and suggests high versatility regarding the types of exogenous genes that can be introduced. While Kooij et al. previously identified a silent intergenic locus in P. berghei as a region suitable for exogenous gene integration28, the region targeted in this study represents a distinct locus that also supports strong transgene expression. It is likely that additional intergenic loci exist where exogenous gene integration does not impact the parasite life cycle; and utilizing these regions could enable multiple rounds of genetic modification without disrupting any endogenous gene functions. Although we focused on fluorescent protein expression in this study, we believe that these loci could facilitate the introduction of other functional cassettes, such as Cas9 or Cre recombinase; thereby establishing more efficient parental lines for targeted gene editing or inducible gene repression systems. Ultimately, by providing a robust and versatile genetic toolbox, this study offers a transformative platform that will significantly accelerate our understanding of P. falciparum biology and facilitate the development of innovative malaria control strategies. Materials and methods Ethics statement Ethical approval for the use of human erythrocytes and plasma from the Japanese Red Cross Tokyo Blood Center were granted in accordance with the Medical Research Ethical Committee of the Institute of Science Tokyo. All animal experiments were approved by the Institutional Animal Care and Use Committee of Institute of Science Tokyo (Approval No. A2025-150A, A2026-088A) and were conducted in accordance with relevant guidelines and regulations consistent with the ARRIVE guidelines (https://arriveguidelines.org). Mice were euthanized by gradual-fill carbon dioxide (CO₂) inhalation using procedures consistent with the AVMA Guidelines for the Euthanasia of Animals (2020 Edition) (https://www.avma.org/resources-tools/avma-policies/avma-guidelines-euthanasia-animals). Parasite strains and in vitro cultivation The strain NF54 is known as a high gametocyte producing P. falciparum line and was utilized as the parental strain in this study37. NF54 parasites were cultivated under 5% CO2 and 5% O2 with human type O erythrocytes at 2% hematocrit in a complete medium consisting of RPMI Medium 1640 (23,400–062, Thermo Fisher Scientific, Carlsbad, CA, USA) containing 5.0% human type O serum, 0.5% AlbuMAX II (Thermo Fisher Scientific), 0.225% sodium hydrogen carbonate (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), and 0.38 mM hypoxanthine (Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10 µg/ml gentamicin (FUJIFILM Wako). Human serum and erythrocytes were obtained from the Japanese Red Cross Tokyo Blood Center. The parasite was cultured in vitro under low oxygen conditions as described31. For the rodent malaria studies, the Plasmodium berghei ANKA and Plasmodium yoelii 17XNL strains were propagated in female ICR mice (Japan SLC, Shizuoka, Japan) and used as parental lines for the generation of transgenic parasites. Mosquito rearing In this study, Anopheles stephensi SDA500 mosquitoes were used. Larvae were fed a powdered diet (Oriental Yeast Industry, Tokyo, Japan), and adults were maintained on a 3% sucrose solution. Female adult mosquitoes, more than five days after emergence, were allowed to feed on mouse blood and subsequently oviposited. Both larvae and adults were reared at 25 °C and 70% humidity under an automatically controlled 16-h light and 8-h dark cycle. Construction of donor plasmid and guide RNA plasmid The pCas9/sgRNA-cen plasmid was constructed based on a reported method and is a centromere plasmid which carries a Cas9 expression cassette, sgRNA expression cassette, and an hdhfr-yfcu selectable marker35. Candidate 20 bp guide RNA sequences were selected using the CHOPCHOP online tool (https://chopchop.cbu.uib.no), based on predicted high on-target efficiency and minimal off-target potential. A pair of complementary oligonucleotides (pf_sgRNA_F/R) corresponding to the selected guide RNA sequence were annealed and inserted into the BsmBI-digested pCas9/sgRNA-cen plasmid by ligation. The donor DNA plasmid was designed following a described method44. The intergenic region between PF3D7_1022300, annotated as a ZIP domain-containing protein, and PF3D7_1022400, annotated as a serine/arginine-rich splicing factor 4 (PlasmoDB; https://plasmodb.org/plasmo/) was selected as the target site because it represents one of the longest intergenic regions in the genome32. Two partial sequences (pfLH and pfRH) derived from a defined intergenic region of P. falciparum genomic DNA were amplified using specific primers (pf_intergenic_LH-F/R and pf_intergenic_RH-F/R). The pfLH fragment was inserted into the pBluescript II SK( +) vector linearized with KpnI and XhoI using the In-Fusion Snap Assembly Master Mix (Takara Bio Inc., Shiga, Japan). The resulting plasmid was subsequently digested with HindIII and NotI, and the pfRH fragment was inserted into this site. The promoter region of pfhsp90 (PF3D7_0708400) and the 3′ untranslated region (UTR) of pfhsp70 (PF3D7_0818900) were PCR-amplified from genomic DNA using the primer pairs pfhsp90-F/R and pfhsp70-F/R, respectively. The mCherry gene was synthesized using the GeneArt Gene Synthesis service (Invitrogen) and was amplified by PCR with primers mCherry-F/R. The resulting fragments were inserted into the pBluescript II SK( +) vector containing pfLH and pfRH, which had been digested with XhoI and HindIII, using the In-Fusion cloning method. The resulting construct, which harbors the mCherry expression cassette flanked by intergenic sequences, was linearized using KpnI and NotI and used as a donor DNA template for targeted genomic integration to generate the NF54-mCh transgenic parasite line. For transfection in Plasmodium berghei and Plasmodium yoelii, a pCas9/sgRNA plasmid was used which carries a Cas9 expression cassette, sgRNA expression cassette, and an hdhfr-yfcu selectable marker45. Each pair of complementary oligonucleotides (pb_sgRNA_F/R or py_sgRNA_F/R), corresponding to the selected guide RNA sequence, were annealed and ligated into the BsmBI-digested pCas9/sgRNA plasmid. For the donor DNA plasmid of P. berghei, the promoter region of pbhsp70 (PBANKA_0711900) and the 3′ UTR of pbhsp70 were PCR-amplified from P. berghei genomic DNA using the primer pairs pbhsp70_5UTR-F/R and pbhsp70_3UTR-F1/R1, respectively. The mGreenLantern gene and the Akaluc reporter gene were synthesized using the GeneArt Gene Synthesis service and individually PCR-amplified using the primer pairs mGL-F/R and T2A-Akaluc-F/R, respectively. The two fragments were then joined by overlap PCR using the primers mGL-F and Akaluc-R. The three fragments were subsequently cloned into the SalI and XhoI digested pBluescript II SK( +) vector via In-Fusion cloning. The intergenic region between P. berghei PBANKA_0506500 and PBANKA_0506600 was selected as the target site based on syntenic genomic alignment corresponding to the intergenic region identified in P. falciparum. Two partial sequences derived from the intergenic region were amplified from P. berghei genomic DNA using specific primers pb_intergenic_LH-F/R and pb_intergenic_RH-F/R. The homologous region (pbRH) fragment was first inserted into the SalI and NotI digested pBluescript II SK( +) vector containing an mGL-T2A-Akaluc expression cassette. The resulting plasmid was then digested with XhoI for the insertion of the other homologous region (pbLH) fragment. Prior to use, the donor DNA plasmid was linearized with KpnI and NotI. In P. yoelii, the intergenic region between PY17X_0507600 and PY17X_0507700 was selected as the target site. For the donor DNA plasmid for P. yoelii, a modified version of the donor DNA plasmid used for P. berghei was employed. Specifically, the plasmid used for P. berghei was digested with BamHI and NotI, and the homologous region (pyRH) was PCR-amplified from P. yoelii genomic DNA using the primers py_intergenic_RH-F/R, together with the 3′ UTR region of pbhsp70, amplified using the primers pbhsp70_3UTR-F2/R2, were inserted by In-Fusion cloning. Subsequently, the resulting plasmid was digested with KpnI and SpeI, and an additional homologous region (pyLH), PCR-amplified using primers py_intergenic_LH-F/R, was inserted by In-Fusion cloning. All oligonucleotides used in this study are listed in Supplementary Table 2. Generation of a transgenic P. falciparum line by CRISPR/Cas9-mediated genome editing Transfection of P. falciparum by the CRISPR/Cas9 genome editing system was performed as described31,35. Briefly, to integrate the mCherry expression cassette into the intergenic locus, 25 µg of a centromere plasmid expressing both Cas9 and sgRNA (pCas9/sgRNA) and 25 µg of the linear donor DNA were prepared (see Fig. 1A). Synchronized mature schizonts (0.1 × 109) were purified and mixed with the pCas9/sgRNA plasmid and the donor DNA was dissolved in 100 μl of P3 Primary Cell Solution (Lonza, Basel, Switzerland). Electroporation was performed using the FP-137 program on a 4D-Nucleofector™ device. After electroporation, transfected parasites were cultured in 5 ml of complete medium with fresh erythrocytes, then pyrimethamine drug selection of transgenic parasites was initiated at a concentration of 25 ng/mL 72 h after transfection and continued for 10 days. Genome editing of the parasites was confirmed by genotyping PCR using the primer pair pfcheck-F/R. Two clonal parasite lines were isolated by limiting dilution. The nucleotide sequence of the transgenic locus was confirmed by Sanger sequencing. Southern blotting Southern blot analysis was performed as described46. Briefly, genomic DNAs of NF54 and NF54-mCh were extracted from blood stage parasites by standard phenol/chloroform methods and digested with the restriction enzymes, NheI and SpeI. Fragmented DNAs (2 µg) were electrophoretically separated on a 0.8% agarose gel and blotted onto the nylon transfer membrane Amersham Hybond™-N+ (GE HealthCare, Buckinghamshire, England). The DNA probe derived from PF3D7_1022300 (Probe 1), indicated by a solid bar in Fig. 1A, was generated using primers probe1-F/R, and the probe derived from the mCherry gene (Probe 2) was generated using primers probe2-F/R. The hybridized signals were detected and recorded by iBright 1500 (Invitrogen, Waltham, MA, USA). Whole-genome sequencing PCR free libraries for Illumina sequencers were prepared from genomic DNA using QIAseq FX DNA Library UDI Kit (Qiagen). Libraries were sequenced in MiniSeq (Illumina) using 150PE Mid Output Sequencing Kit (300-cycles). In total, 1.52 Gbp (× 65) and 1.75 Gbp (× 75) were sequenced for NF54 and NF54-mCh, respectively. Raw NGS reads were mapped to the 3D7 reference assembly (genbank accession: GCA_000002765.3) by bwa mem (v0.7.17-r1198-dirty)47 and coordinate sorted by samtools (v1.19.2)48. Variants compared to the 3D7 genome were called by freebayes (v1.3.6)49 as ploidy (-p) set to 2. The called variants in VCF file were filtered by QUAL > 50. Unique alleles in NF54-mCh were defined as those supported by > 5% reads of total depth at sites with depth > 20. Raw sequencing data have been deposited in the DDBJ Sequence Read Archive (DRA) under accession number DRR894158 and DRR894159. Gametocyte culture of P. falciparum Gametocyte culture was performed as described with some modifications50. Gametocyte cultures were initiated at 0.5% to 0.9% parasitemia with human type O erythrocytes at 5% hematocrit in 5 mL of complete medium per well using 6-well plates. The complete medium consisted of RPMI Medium 1640 containing 50 mg/L of hypoxanthine, 2 g/L sodium bicarbonate (Thermo Fisher Scientific), 2 g/L of D ( +)-Glucose (FUJIFILM Wako), and 10% human type AB serum (BioWest, Nuaille, France). To induce gametocytogenesis, parasites were maintained for 15 to 17 days, ensuring that the temperature did not fall below 37 °C during daily medium change, but without the addition of fresh human erythrocytes. Gametocytemias and the stages of maturation were determined by Giemsa staining of thin blood smears on glass slides. Male gametocyte maturation was assessed by counting the number of exflagellation centers. To this end, infected red blood cells were adjusted to 10% hematocrit in the serum at room temperature to induce activation and applied to a hemocytometer. After incubation at 20 °C for 15 min, exflagellation centers were quantified using light microscopy. Fluorescence imaging For P. falciparum intraerythrocytic stages, cultured or activated parasites were collected and the nuclei were stained with 5 µg/mL Hoechst 33342 (H3570, Thermo Fisher Scientific) for 5 min at 37 °C. After removal of the supernatant, thin blood smears were prepared on the glass slides. A drop of immersion oil was applied directly onto the smear, which was then covered with a coverslip. Fluorescence images were captured using a DP74 camera mounted on a BX53 microscope (Olympus, Tokyo, Japan), and image analysis was performed using Fiji. For rodent malaria parasites, 2 µL of tail blood was suspended in 100 µL RPMI 1640 medium supplemented with 25% FCS; the subsequent nuclear staining and imaging procedures were performed as described above. Immunofluorescence assay Gametocytes cultured for more than 14 days were prepared as thin smears. The parasites were fixed with acetone for 2 min and permeabilized with 0.1% Triton X-100, followed by incubation with rabbit anti-PfG377 antiserum (1:1000)51 and mouse anti-α-tubulin monoclonal antibody (1:2000; T5168, Sigma-Aldrich) for the detection of female and male gametocytes, respectively. Subsequently, they were incubated with goat anti-rabbit IgG (H + L) Alexa Fluor Plus 488-conjugated and goat anti-mouse IgG (H + L) Alexa Fluor Plus 594-conjugated secondary antibodies (1:500; A32731, A32742, Thermo Fisher Scientific) along with Hoechst 33342 (5 µg/mL) for the staining of nuclei. To evaluate the egress of female gametocytes from red blood cells, cultured gametocytes were activated as described in the “Gametocyte culture” section and prepared as thin smears. The parasites were fixed with 4% paraformaldehyde solution and permeabilized with 0.1% Triton X-100. Mouse anti-Pfs25 monoclonal antibody (1:2000; MRA-28, MR4) and rabbit anti-human erythrocyte antibodies (1:8000; 209–4139, Rockland Immunochemicals, Limerick, PA, USA) were used as markers. Goat anti-mouse IgG (H + L) Alexa Fluor Plus 488-conjugated and goat anti-rabbit IgG (H + L) Alexa Fluor Plus 647-conjugated secondary antibodies (1:500; A32723, A32733, Thermo Fisher Scientific) and Hoechst 33342 (5 µg/mL) were employed for detection. The stained thin smears were mounted with ProLong Diamond (Thermo Fisher Scientific). Images were captured using a DP74 camera mounted on a BX53 microscope, and image analysis was performed using Fiji. For immunofluorescence assays of HC-04 hepatic cells, the infected cells were fixed with a 4% paraformaldehyde solution on day 5 after inoculation with sporozoites which were dissected from salivary glands infected with mCherry transgenic or NF54 parental parasites. After permeabilization with 0.1% Triton X-100, the cells were incubated with rabbit anti-PfEXP2 antiserum (1:2000)52 to label the parasitophorous vacuole membrane, followed by incubation with Alexa Fluor Plus 488-conjugated secondary antibody (1:500) and 5 µg/mL Hoechst 33342. Images were acquired using the confocal microscope Leica Stellaris 5. Membrane-feeding assay After 15 to 17 days of gametocyte culture, parasite cultures with robust gametocytemias and exflagellation center assays were fed to mosquitoes using a standard membrane feeding assay as described50. Briefly, the cultures of P. falciparum gametocytes were centrifuged at 900 g for 5 min using a centrifuge at 37 °C. The supernatant was replaced with human type AB serum, and 50% hematocrit erythrocytes were added to adjust the gametocytemia to 0.5%. Four- to six-day old female Anopheles stephensi mosquitoes were fed on gametocytes through Hemotek membrane feeding systems (Hemotek, Blackburn, UK). Female mosquitoes were fed a 10% sucrose solution containing 0.05% gentamicin for 3 days prior to blood feeding, and afterwards the mosquitoes were kept in a 10% sucrose solution at 26 °C and 60% humidity. Ookinete and oocyst development were assayed by dissection of mosquito midguts at days 1 and 11 post membrane feeding, respectively. The dissected midguts were ground in RPMI 1649 Medium supplemented with 5 µg/mL Hoechst 33342 to make smears on glass slides for detecting ookinetes. For observation of fluorescent oocysts, dissected midguts were mounted on glass slide and imaged. To assay oocyst numbers, isolated midguts were stained with 0.5% mercurochrome in PBS for 10 min, followed by imaging. For imaging of sporozoite-infected salivary glands, the glands were dissected at 18 days post-feeding and stained with 5 µg/mL Hoechst 33342 and CellMask™ Green Plasma Membrane Stain (1:1000 dilution; Themo Fisher Scientific) at room temperature for 5 min, followed by imaging with a Leica Stellaris 5 confocal microscope (Leica Microsystems, Wetzlar, Germany). For non-invasive observation of salivary glands with sporozoites, mosquitoes (with legs and wings removed) were anesthetized on ice and imaged using a Leica MZ10 fluorescence stereo microscope. To quantify sporozoites, more than 70 salivary glands were dissected from infected mosquitoes at day 18 post membrane feeding and homogenized in a 1.5 mL microcentrifuge tube. The number of sporozoites in the homogenates was determined using a hemocytometer under a light microscope. Sporozoite infection of human hepatocytes HC-04 cells41 were cultured in Dulbecco’s Modified Eagle Medium / Ham’s F-12 (048–29,785; FUJIFILM Wako), supplemented with heat-inactivated 10% FBS and 1% penicillin–streptomycin solution (100 U/mL penicillin, 100 μg/mL streptomycin) at 37 °C in 5% CO2. The HC-04 cells were transferred to a Nunc Lab-Tek 8-well Chamber Slide (Thermo Fisher Scientific) at 1.0 × 105 per well and incubated for 24 h, and then 5.0 × 104 sporozoites were inoculated into each well. After the addition of sporozoites, wells containing HC-04 cells were cultured in RPMI 1640 Medium (4.5 gm/L glucose, 187–02,705; FUJIFILM Wako) supplemented with heat-inactivated 10% FBS, 1% GlutaMAX (Thermo Fisher Scientific), 1% penicillin–streptomycin solution and 1 μg/mL amphotericin B. The culture medium was refreshed every 24 h. Experimental infection of a human liver mouse with sporozoites A humanized liver TK-NOG chimeric mouse (> 70% chimeric) was used for this study and was purchased from CLEA Japan (CLEA Japan, Inc., Tokyo, Japan). A total of 0.1 × 106 salivary gland sporozoites were suspended in 100 µl of RPMI 1640 medium supplemented with heat-inactivated 2% FBS and were intravenously injected into the chimeric mouse. On days 6 and 8 post sporozoite inoculation, 400 µl of 50% hematocrit human erythrocytes in RPMI 1640 Medium supplemented with 2% FBS was injected intravenously. Four hours after human erythrocyte injection on day 8, blood was collected by cardiac puncture. After thrice washing the collected blood with complete medium, parasites were cultured in vitro as described above. Generation of transgenic P. berghei and P. yoelii lines by CRISPR/Cas9-mediated genome editing In this study, the rodent malaria parasites P. berghei ANKA strain and P. yoelii 17XNL strain were used. Transfection of P. berghei and P. yoelii was performed as described with some modifications45. Briefly, 5 µg of a pCas9/sgRNA plasmid and 5 µg of the linear donor DNA were introduced into purified schizonts using the FI-115 program on a 4D-Nucleofector™ device (see Fig. 6A). After electroporation, the parasites were immediately injected intravenously into ICR mice, then pyrimethamine drug selection of transgenic parasites was initiated 30 h after transfection by administrating the drug via drinking water (70 µg/mL) for 5 days. Parasites were initially screened by genotyping PCR using primer pair pbcheck-F/R for P. berghei and pycheck-F/R for P. yoelii. Clonal isolation was performed by limiting dilution, and the resulting transgenic locus was verified by Sanger sequencing. Western blot analysis Blood collected from mice infected with P. berghei was passed through a cellulose powder D (Toyo Roshi Kaisha, Tokyo, Japan) column to remove leukocytes, incubated overnight in vitro, and enriched schizonts were obtained. After erythrocytes were lysed using lysis buffer (154.4 mM NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA-2Na), parasites were recovered by centrifugation, resuspended in 1 × SDS loading buffer containing 5% 2-mercaptoethanol, and heated at 95 °C for 5 min. Samples (1 × 106 parasites per lane) were separated on a 5–20% gradient gel (ATTO CORPORATION, Tokyo, Japan) and transferred to a PVDF membrane (ATTO CORPORATION) by semidry blotting. The blotted membrane was blocked with 4% skim milk overnight and incubated with primary antibody. Detection of mGL utilized an HRP-conjugated rabbit anti-GFP antibody (1:5000; MEDICAL & BIOLOGICAL LABORATORIES CO., LTD., Tokyo, Japan). Akaluc was detected using a rabbit anti-luciferase antibody (1:1000; MEDICAL & BIOLOGICAL LABORATORIES), and a rabbit anti-PbHSP70 antiserum (1:100,000)9 was used as an internal control. For the detection of both Akaluc and PbHSP70, an HRP-conjugated goat anti-rabbit IgG (H + L) secondary antibody (1:10,000; Jackson ImmunoReserch, West Grove, PA, USA) was used. Rodent malaria parasite growth, mosquito transmission assays, and in vivo imaging To monitor asexual blood-stage growth of P. berghei, C57BL/6 mice (5 to 6 week-old females, Japan SLC) were intravenously inoculated with 2000 sporozoites. For mosquito stage analysis, A. stephensi mosquitoes were allowed to feed on infected ICR mice (5 to 6 week-old females) and were subsequently maintained in an incubator at 20 °C for P. berghei or 24 °C for P. yoelii. For P. berghei, mosquitoes were dissected at 24 h, 10 days, and 20 days post-blood feeding to examine the fluorescence of ookinetes, oocysts, and sporozoites, respectively. For P. yoelii, oocysts and sporozoites were examined 7 and 14 days post-blood feeding, respectively. The salivary glands were dissected and stained at room temperature for 5 min with 5 µg/mL Hoechst 33342 and CellMask™ Orange Plasma Membrane Stain (1:1000 dilution; Thermo Fisher Scientific), for 5 min before confocal imaging. For in vivo bioluminescence imaging, female ICR mouse were intravenously inoculated with 10 × 103 sporozoites. At 24 h post-inoculation, 100 µL of 5.5 mM Akalumine-HCl (FUJIFILM Wako) was injected intraperitoneally under anesthesia. Images were then taken 10 min after the injection using the Newton 7.0 (Vilber, Collégien, France). Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2 Supplementary Material 3 Supplementary Material 3